Bayesian Capital Management’s Pearson PSO Stock Holding History

Bayesian Capital Management’s Portfolio PSO Stock Details PSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,500	Closed	-$177K	–	437
2025 Q3	$177K	Buy	+12,500	New	+$180K	0.04%	471
2022 Q2	–	Sell	-21,400	Closed	-$213K	–	1023
2022 Q1	$213K	Buy	+21,400	New	+$193K	0.03%	634

Other funds holding PSO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bayesian Capital Management's PSO Position: Q4 2025 in Review

Bayesian Capital Management sold out of Pearson (PSO) in Q4 2025, closing a stake of 12,500 shares — an estimated $177K sold.

Bayesian Capital Management first reported a position in PSO in Q1 2022 and held it in 2 quarters. The position peaked at $213K in Q1 2022. 193 funds tracked by Wall St. Rank hold PSO as of Q4 2025.

Bayesian Capital Management reported no remaining Pearson position as of Q4 2025 after selling out during the quarter.
Bayesian Capital Management sold 12,500 Pearson shares in Q4 2025, an estimated $177K.
Bayesian Capital Management first reported a position in Pearson in Q1 2022 and held it in 2 quarters.
Bayesian Capital Management's Pearson position peaked at $213K in Q1 2022.
193 funds tracked by Wall St. Rank held Pearson as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.